Tissue typing in support of unrelated hematopoietic cell transplantation

Tissue Antigens

Volumn 61, Issue 1, 2003, Pages 1-11

  Petersdorf, Effie W ^a   Anasetti, C ^a   Martin, P J ^a   Hansen, J A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allele; Antigen; Graft failure; GVHD; HLA; Unrelated donor

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

CHRONIC MYELOID LEUKEMIA; GENE FREQUENCY; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNE RESPONSE; MORTALITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TISSUE TYPING; TREATMENT OUTCOME;

ALLELES; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037215723     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.610101.x     Document Type: Review

References (77)

1. Al-Daccak R, Loiseau P, Rabian C et al. HLA-DR, DQ, and/or DP genotypic mismatches between recipient-donor pairs in unrelated bone marrow transplantation and transplant clinical outcome. Transplantation 1990: 50: 960-4.
2. Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB, Gorski J. Future directions in selection of donors for bone marrow transplantation: role of oligonucleotide genotyping. Transplant Proc 1991: 23: 1699-700.
3. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1991: 33: 267-75.
4. Tiercy JM, Morel C, Freidel AC et al. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci U S A 1991: 88: 7121-5.
5. Santamaria P, Reinsmoen NL, Lindstrom AL et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994: 83: 280-7.
6. Fernández-Viña MA, Lazaro AM, Sun Y, Miller S, Forero L, Stastny P. Population diversity of B-locus alleles observed by high-resolution DNA typing. Tissue Antigens 1995: 45: 153-68.
7. Nademanee A, Schmidt GM, Parker P et al. The outcome of matched unrelated donor bone marrow transplantation in patients with hematological malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 1995: 86: 1228-34.
8. Martinelli G, Farabegoli P, Buzzi M et al. Fingerprinting of HLA class I genes for improved selection of unrelated bone marrow donors. Eur J Immunogenet 1996: 23: 55-65.
9. Nagler A, Brautbar C, Slavin S, Bishara A. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity. Bone Marrow Transplant 1996: 18: 891-7.
10. Petersdorf EW, Longton GM, Anasetti C et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A 1996: 93: 15358-63.
11. Pursall MC, Clay TM, Bidwell JL. Combined PCR-heteroduplex and PCR-SSCP analysis for matching of HLA-A, B and C allotypes in marrow transplantation. Eur J Immunogenet 1996: 23: 41-53.
12. Speiser DE, Tiercy JM, Rufer N et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996: 87: 4455-62.
13. Grundschober C, Rufer N, Sanchez-Mazas A et al. Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic lymphocytes. Tissue Antigens 1997: 6: 612-23.
14. Hurley CK, Schreuder GMT Marsh SGE, Lau M, Middleton D, Noreen H. The search for HLA-matched donors. a summary of HLA-A*-B*-DRB1/3/4/5* alleles and their association with serologically defined HLA-A-B, DR antigens. Tissue Antigens 1997: 50: 401-18.
15. Szmania S, Keever-Taylor CA, Baxter-Lowe LA. Automated nucleotide sequencing reveals substantial disparity between the HLA-A2 genes of bone marrow transplant recipients and donors. Human Immunol 1997: 56: 77-83.
16. Arguello R, Avakian H, Goldman JM et al. A novel method for simultaneous high-resolution identification of HLA-A, HLA-B and HLA-Cw alleles. Nature Genet 1998: 18: 192-4.
17. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998: 1: 3515-20.
18. Scott I, O'Shea J, Bunce M et al. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: Implications for unrelated bone marrow donor selection. Blood 1998: 12: 4864-71.
19. Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SY. DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood 1999: 93: 399-409.
20. Zanone-Ramseier R, Gratwohl A, Gmur J, Roosnek E, Tiercy J-M. Sequencing of two HLA-A blank alleles: implications in unrelated bone marrow donor matching. Transplantation 1999: 67: 1336-41.
21. Hurley CK, Baxter-Lowe LA, Begovich AB et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant 2000: 25: 385-93.
22. Sayer D, Whidborne R, Brestovac B, Trimboli F, Witt C, Christiansen F. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 2002: 57: 46-54.
23. Beatty PG, Mori M, Milford E et al. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995: 60: 778-83.
24. Lonjou C, Clayton J, Cambon-Thomsen A, Raffoux C. HLA-A-B-DR haplotype frequencies in France. Implications for recruitment of potential bone marrow donors. Transplantation 1995: 60: 375-83.
25. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population. The National Marrow Donor Program Donor Registry. Transplantation 1997: 64: 1017-27.
26. Oudshoorn M, Cornelissen JJ, Fibbe WE et al. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997: 20: 1011-7.
27. Schipper RF, D'Amaro J, Bakker JT, Van Rood JJ, Oudshoorn M. HLA gene and haplotype frequencies in bone marrow donors worldwide registries. Human Immunol 1997: 52: 54-71.
28. Oh HB, Kim SI, Park MH, Akaza T, Juji T. Probability of finding HLA-matched unrelated marrow donors for Koreans and Japanese from the Korean and Japan Marrow Donor Programs. Tissue Antigens 1999: 53: 347-9.
29. Velickovic ZM, Carter JM. Feasibility of finding an unrelated bone marrow donor on international registries for New Zealand patients. Bone Marrow Transplant 1999: 23: 291-4.
30. Brown J, Poles A, Brown CJM, Contreras Vavarrete CV. HLA-A, -B and -DR antigen frequencies of the London Cord Blood Bank units differ from those found in established bone marrow donor registries. Bone Marrow Transplant 2000: 25: 475-81.
31. Hansen JA, Yamamoto K, Petersdorf E, Sasazuki T. The role of HLA matching in hematopoietic cell transplantation. Rev Immunogen 1999: 1: 359-73.
32. Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998: 339: 1177-85.
33. Marsh SG, Bodmer JG. Albert ED et al. Nomenclature for factors of the HLA system, 2000. Tissue Antigens 2001: 57: 236-8.
34. Takahashi K, Juji T, Miyazaki H. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched bone marrow transplantation. Transfusion 1989: 29: 311-3.
35. Schipper RF, D'Amaro J, Oudshoorn M. The probability of finding a suitable related donor for bone marrow transplantation in extended families. Blood 1996: 87: 800-4.
36. Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Human Immunol 2000: 61: 834-40.
37. Tiercy J-M, Bujan-Lose M, Chapuis B et al. Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor? Bone Marrow Transplant 2000: 26: 437-41.
38. Pawelec G, Ehninger G, Schmidt H, Wernet P. HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation. Transplantation 1986: 42: 558-60.
39. Keever-Taylor CA, Bredeson C, Loberiza FR et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT. Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001: 7: 620-30.
40. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989: 320: 197-204.
41. Ash RC, Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990: 322: 485-94.
42. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990: 323: 1818-22.
43. Gajewski JL, Ho WG, Feig SA et al. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation 1990: 50: 244-9.
44. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991: 51: 443-7.
45. Kato Y, Mitsuishi Y, Cecka M et al. HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants. Transplantation 1991: 52: 374-6.
46. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993: 328: 593-602.
47. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first 2 years. Ann Intern Med 1993: 119: 207-12.
48. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993: 81: 1923-32.
49. Anasetti C, Hansen JA. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors. Transfus Sci 1994: 15: 221-30.
50. Keever CA, Leong N, Cunningham I et al. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 1994: 14: 137-45.
51. Davies SM, Shu XO, Blazar BR et al. Unrelated donor bone marrow transplantation: influence of HLA-A and - B incompatibility on outcome. Blood 1995: 86: 1636-42.
52. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995: 86: 1606-13.
53. Gajewski J, Gjertson D, Cecka M et al. The impact of T-cell depletion on the effects of HLA-DRB1 and DQB allele matching in HLA serologically identical unrelated donor bone marrow transplantation. Biol Blood Marrow Transplant 1997: 3: 76-82.
54. Madrigal JA, Scott I, Arguello R, Szydlo R, Little AM, Coldmann JM. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997: 157: 153-66.
55. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997: 89: 1818-23.
56. Przepiorka D, Petropoulos D, Mullen C et al. Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation. Bone Marrow Transplant 1999: 23: 1291-5.
57. Varney MD, Lester S, McCluskey J, Gao X, Tait BD. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Hum Immunol 1999: 60: 532-8.
58. Davies SM, Kollman C, Anasetti C et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program. Blood 2000: 96: 4096-102.
59. McGlave PB, Shu XO, Wen W et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program. Blood 2000: 95: 2219-25.
60. Prezpiorka D, Saliba R, Cleary K et al. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1. Biol Blood Marrow Transplant 2000: 6: 190-7.
61. Ferrara GB, Bacigalupo A, Lamparelli T et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001: 98: 3150-5.
62. Flomenberg N, Baxter-Lowe LA, Confer D et al. Impact of HLA-class I and class II high resolution matching on outcomes of unrelated donor BMT. Blood 2001: 98: 813a.
63. Loiseau P, Esperou H, Busson M et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Blood 2001: 7: 660a.
64. Petersdorf EW, Kollman C, Hurley CK et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia. The US National Marrow Donor Program Experience. Blood 2001: 98: 2922-9.
65. Petersdorf EW, Gooley T, Malkki M et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001: 112: 988-94.
66. Petersdorf EW, Hansen JA, Martin PJ et al. Major histocompatibility complex class I alleles and antigens in hematopoietic cell transplantation. N Engl J Med 2001: 345: 1794-800.
67. Morishima Y, Sasazuki T, Inoko H et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-Dr matched unrelated donors. Blood 2002: 99: 4200-6.
68. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985: 313: 765-71.
69. Servida P, Gooley T, Hansen JA et al. Improved survival of haploidentical related donor marrow transplants mismatched for HLA-A or B versus HLA-DR. Blood 1996: 88: 484a.
70. Pocock C, Szydlo R, Davis J et al. Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell dose. The Hematol J 2001: 2: 265-71.
71. Sierra J, Storer B, Hansen JA et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000: 26: 397-404.
72. Hansen JA, Gooley T, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998: 338: 962-8.
73. Sierra J, Storer B, Hansen JA et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997: 89: 4226-35.
74. Shaw BE, Pay AL, Mayor N et al. High resolution molecular typing to ensure allele level matching for six highly polymorphic HLA antigens increases the overall survival in volunteer donor stem cell transplantation, however 'perfect' matches are found in only 10% of pairs. Blood 2001: 98: 668a.
75. Drobyski WR, Klein J, Flomenberg N et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 2002: 99: 806-14.
76. Wade JA, Takemoto SK, Thompson F et al. No deleterious effect of HLA-mismatching outside cross-reactive groups (CREG) compared to within CREG mismatches following unrelated donor bone marrow transplant. Biol Blood Marrow Transplant 2001: 7: 96.
77. Elsner HA, Blasczyk R. Sequence similarity matching: proposal of a structure-based rating system for bone marrow transplantation. Eur J Immunogen 2002: 29: 229-36.